Oxidized LDL induces phosphorylation of non-muscle myosin IIA heavy chain in macrophages

BMB Reports

Volumn 48, Issue 1, 2015, Pages 48-53

  Park, Young Mi ^a,b  

^a Ewha Womans University School of Medicine   (South Korea)

^b Ewha Womans University   (South Korea)

Author keywords

Atherosclerosis; Cd36; Macrophage; Non muscle myosin; Oxidized LDL

Indexed keywords

MUS;

CD36 ANTIGEN; LOW DENSITY LIPOPROTEIN; MYOSIN IIA; OXIDIZED LOW DENSITY LIPOPROTEIN; PROTEIN KINASE C; PROTEIN KINASE INHIBITOR;

ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CELL CULTURE; CYTOLOGY; DEFICIENCY; DRUG EFFECTS; GENETICS; HUMAN; IMMUNOPRECIPITATION; MACROPHAGE; METABOLISM; MOUSE; PHOSPHORYLATION;

ANIMALS; ANTIGENS, CD36; CELLS, CULTURED; HUMANS; IMMUNOPRECIPITATION; LIPOPROTEINS, LDL; MACROPHAGES; MICE; MICE, INBRED C57BL; NONMUSCLE MYOSIN TYPE IIA; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS;

EID: 84922292046     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2015.48.1.186     Document Type: Article

References (50)

1. Steinbrerg D, Parthasarathy S, Carew TE, Khoo JC, and Witztum JL (1989) Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320, 915-924
2. Steinbrecher UP (1987) oxidation of human low density lipoprotein results in derivatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products. J Biol Chem 262, 3603-3608
3. Stocker R and Keaney KJ Jr (2005) New insights on oxidative stress in the artery wall. J Throm Haem 3, 1825-1834
4. Stocker R and Keaney JF Jr (2004) Role of oxidative modifications in atherosclerosis. Physiol Rev 84, 1381-1478
5. Rajavashisth TB, Andalibi A, Territo MC et al (1990) Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low density lipoproteins. Nature (London) 344, 254-257
6. Cushing SD, Berliner JA, Valente AJ et al (1990) Minimally modified low density lipoprotein inducesmonocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci U S A 87, 5134-5138
7. Carlos TM, and Harlan JM (1990) Membrane proteins involved in phagocyte adherence to endothelium. Immunol Rev 114, 5-28
8. Khan BV, Parthasarathy SS, Alexander RW, and Medford RM (1995) Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells. J Clin Invest 95, 1262-1270
9. Chatterjee S, and Ghosh N (1996) Oxidized low density lipoprotein stimulates aortic smooth muscle cell proliferation. Glycobiology 6, 303-311
10. Brown MS, and Goldstein JL (1990) Atherosclerosis. Scavenging for receptors. Nature 343, 508-509
11. Salonen JT, Nyyssonen K, Salonen R et al (1997) Lipoprotein oxidation and progression of carotid atherosclerosis. Circulation 95, 840-845
12. Duden R, Ho WC, Allan VJ, and Kreis TE (1990) What's new in cytoskeleton-organelle interactions? Relationship between microtubules and the Golgi-apparatus. Pathol Res Pract 186, 535-541
13. Zhao B, Ehringer WD, Dierichs R, and Miller FN (1997) Oxidized low-density lipoprotein increases endothelial intracellular calcium and alters cytoskeletal f-actin distribution. Eur J Clin Invest 27, 48-54
14. Chouinard JA, Grenier G, Khalil A, and Vermette P (2008) Oxidized-LDL induce morphological changes and increase stiffness of endothelial cells. Exp Cell Res 314, 3007-3016
15. Chow S, Lee R, Shih SH and Chen J (1998) Oxidized LDL promotes vascular endothelial cell pinocytosis via a prooxidation mechanism. FASEB J 12, 823-830
16. Miller YI, Worrall DS, Funk CD, Feramisco JR, and Witztum JL (2003) Actin polymerization in macrophages in response to oxidized LDL and apoptotic cells: Role of 12/15-Lipoxygenase and Phosphoinositide 3-Kinase. Mol Biol Cell 14, 4196-4206
17. Park YM, Febbraio M, and Silverstein RL (2009) CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima. J Clin Invest 119, 136-145
18. Park YM, Drazba JA, Vasanji A, Egelhoff T, Febbraio M, and Silverstein RL (2012) Oxidized LDL/CD36 interaction induces loss of cell polarity and inhibits macrophage locomotion. Mol Biol Cell 23, 3057-3068
19. Clark K, Langeslag M, Figdor CG, and van Leeuwen FN (2007) Myosin II and mechanotransduction: a balancing act. Trends Cell Biol 17, 178-186
20. Conti MA, and Adelstein RS (2008) Nonmuscle myosin II moves in new directions. J Cell Sci 121, 11-18
21. Vicente-Manzanares M, Zareno J, Whitmore L, Choi CK, and Horwitz AF (2007) Regulation of protrusion, adhesion dynamics, and polarity by myosin IIA and IIB in migrating cells. J Cell Biol 176, 573-580
22. Choi CK, Vicente-Manzanares M, Zareno J, Whitmore LA, Mogilner A, and Horwitz AR (2008) Actin and 〈 -actinin orchestrate the assembly and maturation of nascent adhesions in a myosin II motor-independent manner. Nat Cell Biol 10, 1039-1050
23. Rosado LA, Horn TA, McGrath SC, Cotter RJ, and Yang JT (2011) Association between 〈 4 integrin cytoplasmic tail and non-muscle myosin IIA regulates cell migration. J Cell Sci 124, 483-492
24. Kim JH, Wang A, Conti MA, and Adelstein RS (2012) Nonmuscle myosin II is required for internalization of the epidermal growth factor receptor and modulation of downstream signaling. J Biol Chem 287, 27345-27358
25. Kumari S, Vardhana S, Cammer M et al (2012) T lymphocyte myosin IIA is required for maturation of the immunological synapse. Front Immunol 3, article 230
26. Somlyo AP, and Somlyo AV (2008) Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 83, 1325-1358
27. Dulyaninova NG, House RP, Betapudi V, and Bresnick AR (2007). Myosin-IIA heavy-chain phosphorylation regulates the motility of MDA-MB-231 carcinoma cells. Mol Biol Cell 18, 3144-3155
28. Straussman R, Even L, and Ravid S (2001) Myosin II heavy chain isoforms are phosphorylated in an EGF-dependent manner: involvement of protein kinase C. J Cell Sci 114, 3047-3057
29. Ludowyke RI, Elgundi Z, Kranenburg T et al (2006) Phosphorylation of nonmuscle myosin heavy chain IIA on Ser1917 is mediated by protein kinase C beta II and coincides with the onset of stimulated degranulation of RBL-2H3 mast cells. J Immunol 177, 1492-1499
30. Matsumura T, Sakai M, Kobori S et al (1997) Two intracellular signaling pathways for activation of protein kinase C are involved in oxidized low-density lipoprotein-induced macrophage growth. Arterioscler Thromb Vasc Biol 17, 3013-3020
31. Feng J, Han J, Pearce SFA et al (2000) Induction of CD36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-γ. J Lipid Res 41, 688-696
32. Witzum JL, and Steinberg D (2001) The oxidative modification hypothesis of atherosclerosis: Does it hold for humans? Trends Cardiovasc Med 11, 93-102
33. Yla-Herttuala S (1998) Is oxidized low-density lipoprotein present in vivo? Curr Opin Lipidol 9, 337-344
34. Itabe H, Yamamoto H, Imanaka T et al (1996) Sensitive detection of oxidatively modified low density lipoprotein using a monoclonal antibody. J Lipid Res 37, 45-53
35. Tsimikas S (2006) Oxidative biomarkers in the diagnosis and prognosis of cardiovascular disease. Am J cardiol 98, 9-17
36. Silverstein RL, Li W, Park YM, Rahaman SO (2010) Mechanisms of cell signaling by the scavenger receptor CD36; Implications in atherosclerosis and thrombosis. Trans Am Clin Climatol Assoc 121, 206-220
37. Park YM (2014) CD36, a scavenger receptor implicated in atherosclerosis. Exp Mol Med 46, e99
38. Rahaman SO, Lennon DJ, Febbraio M, Podrez EA, Hazen SL, and Silverstein RL (2006) A CD36-dependent signaling cascade is necessary for macrophage foam cell formation. Cell Metab 4, 211-221
39. Collins RF, Touret N, Kuwata H, Tandon NT, Grinstein S, and Trimble WS (2009) Uptake of oxidized low density lipoprotein by CD36 occurs by an actin-dependent pathway distinct from macropinocytosis. J Biol Chem 284, 30288-30297
40. Jones NL, and Willingham MC (1999) Modified LDLs are internalized by macrophages in part via macropinocytosis. Anat Rec 255, 57-68
41. Zeng Y, Tao N, Chung KN, Heuser JE, and Lublin DM (2003) Endocytosis of oxidized low density lipoprotein through scavenger receptor CD36 utilizes a lipid raft pathway that does not require caveolin-1. J Biol Chem 278, 45931-45936
42. Sun B, Boyanovsky BB, Connelly MA, Shridas P, van der Westhuyzen DR, and Webb NR (2007) Distinct mechanisms for OxLDL uptake and cellular trafficking by class B scavenger receptors CD36 and SR-BI. J Lipid Res 48, 2560-2570
43. Even-Faitelson L, and Ravid S (2006) PAK1 and aPKCzeta regulate myosin II-B phosphorylation: a novel signaling pathway regulating filament assembly. Mol Biol Cell 17, 2869-2881
44. Dulyaninova NG, Malashkevich VN, Almo SC, and Bresnick AR (2005) Regulation of myosin-IIA assembly and Mts1 binding by heavy chain phosphorylation. Biochemistry 44, 6867-6876
45. Clark K, Middelbeek J, Lasonder E et al (2008) TRPM7 regulates myosin IIA filament stability and protein localization by heavy chain phosphorylation. J Mol Biol 378, 790-803
46. Bajaj G, Zhang Y, Schimerlik MI et al (2009) N-methyl-d-aspartate receptor subunits are non-myosin targets of myosin regulatory light chain. J Biol Chem 284, 1252-1266
47. Hours MC, and Mery L (2010) The N-terminal domain of the type 1 Ins(1,4,5)P3 receptor stably expressed in MDCK cells interacts with myosin IIA and alters epithelial cell morphology. J Cell Sci 123, 1449-1459
48. Huang Y, Arora P, McCulloch CA, and Vogel WF (2009) The collagen receptor DDR1 regulates cell spreading and motility by associating with myosin IIA. J Cell Sci 122, 1637-1646
49. Rey M, Valenzuela-Fernández A, Urzainqui A et al (2007) Myosin IIA is involved in the endocytosis of CXCR4 induced by SDF-1〈 . J Cell Sci 120, 1126-1233
50. Hatch FT (1968) Practical methods for plasma lipoprotein analysis. Adv Lipid Res 6, 1-68